Dipeptidyl peptidase-4 inhibitors

Wang, T. ., Wang, J. ., Song, Z. ., Miller, E. ., Pate, V. ., Her, Q. ., … Sturmer, T. . (2025). Caution in Handling Switchers in Pharmacoepidemiologic Studies Estimating Treatment Effects: The Example of Dipeptidyl Peptidase-4 Inhibitors and Inflammatory Bowel Disease. Am J Epidemiol. http://doi.org/10.1093/aje/kwaf044
Pradhan, R. ., Patorno, E. ., Tesfaye, H. ., Schneeweiss, S. ., Yin, H. ., Franklin, J. ., … Azoulay, L. . (2022). Glucagon-Like Peptide-1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: Multisite Population-Based Cohort Study. Am J Epidemiol. http://doi.org/10.1093/aje/kwac021